-
Bengal Chemicals to resume production of snake anti-venom
The country’s first anti snake venom-maker, Bengal Chemicals & Pharmaceuticals Ltd. (BCPL), is planning to resume production of its flagship offering...
2019-02-13 15:31 -
MMTC planning to export engineering goods, pharma products
Historically known for its strengths in trade of bulk minerals like iron ore and chrome ore, MMTC is witnessing a downtrend in exports o...
2019-02-13 15:09 -
FDA approves shire constipation drug Motegrity
Sharma is not considered to have a particularly strong late-stage development pipeline, but it recently received new indications for Von...
2019-02-13 14:21 -
FDA approves first drug for treatment of oocytic plasmacytoid dendritic cell
Today,FDA approved Stemline Therapeutics' Elzonris tagraxofusp-erzs injection for the treatment of BPDCN in adults and children 2 years and older.
2019-02-13 14:17 -
Sandoz inks biosimilars commercialization deal with Gan & Lee Pharmaceutical
Gan & Lee will be responsible for manufacturing and development, with support from Sandoz, and shall adhere to the stringent manufacturi...
2019-01-07 18:03 -
Uflex showcases pharma packaging offerings at CPhI India
Considering literacy levels and linguistic diversity of India, Uflex is offering tailor-made consumer discernible packaging solutions, w...
2019-01-07 14:25 -
Lupin and AbbVie in pacht to develop and commercialize novel oncology drugs
AbbVie is committed to pursuing advanced treatment options for patients and we look forward to partnering our expertise in hematological...
2019-01-07 14:20 -
Bristol-Myers Squibb to merge with Celgene in multimillion deal
Transaction will see a combined pharmaceutical company in pole position within the immuno-oncology and the treatment of blood cancers market
2019-01-04 16:23 -
Rentschler Biopharma completes acquisition of US manufacturing site
Company’s first foothold in the US grants access to new technologies, innovation and talent
2019-01-04 16:21 -
Cocrystal Pharma announces worldwide license collaboration agreement with Merck
Cocrystal employs unique structure-based technologies and Nobel Prize winning expertise to create first- and best-in-class antiviral drugs
2019-01-04 16:17
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
